Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
Richard A. Smith(University of Liverpool), Paula Ghaneh(University of Liverpool), Michael Raraty(University of Liverpool), Robert Sutton(University of Liverpool), Fiona Campbell(University of Birmingham), L. Bosonnet, John P. Neoptolemos(University of Liverpool)
Cited by 462
Related Papers
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k